Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia

Recruiting N/A Interventional Study
Schizophrenia Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
University Hospital, Toulouse · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Schizophrenia, affecting 1% of the population, is a persistent disorder characterized by varied symptoms. Antipsychotic medications effectively address positive symptoms (delusions, hallucinations) and relapse but have limited impact on negative symptoms (e.g., blunted affect, anhedonia) and cognitive impairment. These dimensions significantly influence social functioning and quality of life. Comb…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient with a diagnosis of schizophrenia or schizoaffective disorder (DSM-5 TR criteria) * Clinically stable (no full-time hospitalization related to schizophrenia for 3 months) * Regular psychiatric follow-up * Enrolled in at least 1 therapeutic or social out-of-home activit…
Contacts

Soukaina Chouiba

05 61 43 78 63

soukaina.chouiba@ferrepsy.fr

CONTACT

Tudi Gozé, MD

CONTACT